Table 2. Clinical status of NPC cases detected.
|
AJCC/UICC stage
|
||||||
|---|---|---|---|---|---|---|
| Detection | Number of NPC cases | I | II | III | IV | % I and II |
| Routine screening: | 74 | 44 | 6 | 16 | 8 | 67.6 |
| After onset of symptoms | 97 | 7 | 12 | 38 | 40 | 19.6 |
| New cases referred to our clinic | 1629 | 173 | 164 | 578 | 714 | 20.7 |
AJCC/UICC=American Joint Committee of Cancer/International Union Against Cancer; NPC=nasopharyngeal carcinoma.
One hundred and seventy-one NPC cases were detected from study subjects either by clinical examination during routine screening, or when patients presented with symptoms of NPC (see Table 1 for details). Newly diagnosed cases, usually with presence of symptoms and referred to our out-patients clinics during the same time, served as concurrent control cases. Percentage of stages I and II cases detected by routine screening is significantly higher than that detected after onset of symptoms (χ2=154.88, P=0.000), and that of the latter is similar as new cases referred to our clinics (χ2=1.984, P=0.576).